Evidence map›Paper›PMID 36903285›Full record

ArticleMolecules (Basel, Switzerland)2023

Determination of β

Chenggang Cai, Yannan Xiang, Siyi Tian, Zhongce Hu, Zhengyan Hu, Bingjie Ma, Pinggu Wu

Full text read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chenggang CaiCollege of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.ORCID 0000-0002-9519-9803
Yannan XiangCollege of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Siyi TianCollege of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Zhongce HuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
Zhengyan HuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.
Bingjie MaZhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.
Pinggu WuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.

Funding

National Natural Science Foundation of China 31871884the Key Research and Development Program of Guangdong Province 2019B020212001the National Key Research and Development Program of China 2018YFC1603600Zhejiang Basic Public Welfare Research Project LGN19C200003
6 · The paper itself

Abstract

β

Indexed as

ClenbuterolAdrenergic beta-AgonistsChromatography, High Pressure LiquidDigestionSolid Phase ExtractionTandem Mass SpectrometryAdrenergic beta-AgonistsClenbuterolhammatrix effectssolid phase extractionUHPLC-MS/MSβ2-agonist residues

Identifiers

PMID36903285
PMCPMC10004211

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read75
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.